Powered by Lingsoft® Search Expander  | |
RSSAdvances in multiple Sclerosis and Experimental Demyelinating Diseases | ||||||||||||||||||
 |
| |||||||||||||||||
| ||||||||||||||||||
 | | | ||||||||||||||||
| Table of contents 1. Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications S. J. Pittock, M. Rodriguez 2. Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders C. Lucchinetti 3. Multiple Sclerosis Genetics J. P. McElroy, J. R. Oksenberg 4. Imaging of Remyelination and Neuronal Health B. J. Erickson 5. Immunological Aspects of Axon Injury in Multiple Sclerosis C. L. Howe 6. The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease I. A. Scarisbrick 7. Genetic Analysis of CNS Remyelination A. J. Bieber 8. Remyelination in Experimental Models of Toxin-Induced Demyelination W. F. Blakemore, R. J. M. Franklin 9. Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease A. E. Warrington, M. Rodriguez 10. Neuroimaging of Demyelination and Remyelination Models I. Pirko, A. J. Johnson 11. Hormonal Influences in Multiple Sclerosis E. A. Shuster 12. Statins and Demyelination M. S. Weber, S. S. Zamvil 13. Role of Uric Acid in Multiple Sclerosis S. Spitsin, H. Koprowski 14. Neuromyelitis Optica: Clinical Syndrome and the NMO-IgG Autoantibody Marker B. G. Weinshenker, D. M. Wingerchuk DRM-restrictions Printing: not available Clipboard copying: not available | ||||||||||||||||||
| We do not deliver the extra material sometimes included in printed books (CDs or DVDs). | ||||||||||||||||||
|
|
